During the past decade, Kingshill Research Centre conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kingshill Research Centre" are "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials) and "Obsessive-Compulsive Disorder" (1 trials). Many other conditions were trialed in "Kingshill Research Centre" in a lesser frequency.

Most popular intervention types in "Kingshill Research Centre" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "HF0220" (1 trials), "Placebo" (1 trials), "Troriluzole" (1 trials), "bapineuzumab" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kingshill Research Centre" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Kingshill Research Centre". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Kingshill Research Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kingshill Research Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".